Grade 3/4 dermatitis in head and neck cancer patients treated with concurrent cetuximab and IMRT. [electronic resource]
Producer: 20110928Description: 110-7 p. digitalISSN:- 1879-355X
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- administration & dosage
- Case-Control Studies
- Cetuximab
- Cisplatin -- administration & dosage
- Combined Modality Therapy -- adverse effects
- Drug Eruptions -- etiology
- Female
- Head and Neck Neoplasms -- pathology
- Humans
- Male
- Middle Aged
- Prospective Studies
- Radiation Dosage
- Radiodermatitis -- chemically induced
- Radiotherapy, Intensity-Modulated -- adverse effects
- Tumor Burden
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.